Vericel Corporation (VCEL)’s Trend Up, Especially After Today’s Strong Session

March 14, 2018 - By Adrian Mccoy

The stock of Vericel Corporation (NASDAQ:VCEL) is a huge mover today! The stock increased 2.64% or $0.3 during the last trading session, reaching $11.65. About 1.13 million shares traded or 15.95% up from the average. Vericel Corporation (NASDAQ:VCEL) has declined 10.47% since March 14, 2017 and is downtrending. It has underperformed by 27.17% the S&P500.
The move comes after 5 months positive chart setup for the $406.68 million company. It was reported on Mar, 14 by We have $12.00 PT which if reached, will make NASDAQ:VCEL worth $12.20M more.

Vericel Corporation (NASDAQ:VCEL) Ratings Coverage

Among 4 analysts covering Vericel (NASDAQ:VCEL), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Vericel had 12 analyst reports since March 11, 2016 according to SRatingsIntel. The firm has “Buy” rating by Needham given on Friday, March 11. Piper Jaffray initiated Vericel Corporation (NASDAQ:VCEL) rating on Thursday, December 22. Piper Jaffray has “Overweight” rating and $6 target. The rating was maintained by Piper Jaffray with “Buy” on Tuesday, October 3. BTIG Research maintained Vericel Corporation (NASDAQ:VCEL) rating on Monday, March 5. BTIG Research has “Buy” rating and $13.0 target. The rating was maintained by BTIG Research with “Buy” on Tuesday, November 7. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, January 2 report. As per Wednesday, August 9, the company rating was maintained by BTIG Research. Piper Jaffray maintained the stock with “Buy” rating in Wednesday, August 9 report. On Wednesday, November 9 the stock rating was maintained by Needham with “Buy”. The firm has “Neutral” rating by Bank of America given on Tuesday, April 5.

More notable recent Vericel Corporation (NASDAQ:VCEL) news were published by: which released: “Vericel to Report Fourth-Quarter and Full-Year 2017 Financial Results on March …” on February 22, 2018, also with their article: “World Champion Swimmer and Twelve-Time Medalist Dara Torres Partners with …” published on March 05, 2018, published: “Vericel Corp. (VCEL) Has Climbed To A New High Following Q4 Report” on March 05, 2018. More interesting news about Vericel Corporation (NASDAQ:VCEL) were released by: and their article: “Vericel to Present at BioCentury’s 25th Annual Future Leaders in the Biotech …” published on March 09, 2018 as well as‘s news article titled: “Vericel to Present at the 17th Annual Needham Healthcare Conference” with publication date: March 13, 2018.

Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, makes, markets, and sells patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company has market cap of $406.68 million. It markets three autologous cell therapy products, including Carticel and MACI, which are used for the treatment of cartilage defects in the knee; and Epicel, a permanent skin replacement that is used for the treatment of patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area in the United States. It currently has negative earnings. The firm also develops ixmyelocel-T, which is in Phase IIb clinical trial, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.